Is there a diurnal rhythm in the corrected QT (QTc) interval? For more than 25 years, clinician scientists have been working to answer this question. It is an important question because if there is a circadian rhythm in the QTc interval, then the time of
The cardiomyocyte molecular clock regulates the circadian expression of Kcnh2 and contributes to ventricular repolarization
Introduction
The discovery that the incidence of sudden cardiac death (SCD) follows a time-of-day dependence suggests that circadian factors participate in the initiation of lethal arrhythmias.1, 2 Biological circadian rhythms are evolutionarily conserved cycles that repeat every ~24 hours and synchronize behavior and physiology with the daily environment.3, 4 The cardiovascular system shows robust circadian rhythms in blood pressure, heart rate, electrocardiographic (ECG) properties, and gene expression.5 Historically, an increase in SCD in early morning rise hours has been linked to the circadian variations in myocardial ischemic events and autonomic signaling; however, more recent studies also support a cardiomyocyte-specific circadian or molecular clock mechanism in the heart.6, 7, 8
The cellular mechanism responsible for generating biological circadian rhythms is a conserved gene regulatory network composed of a transcriptional-translational feedback loop called the molecular clock, which is expressed in almost all cells including cardiomyocytes.9, 10 The positive limb of the molecular clock is formed by the transcription factors BMAL1 (brain muscle arnt-like1) and CLOCK (circadian locomotor output control kaput), and the negative limb is regulated by periods 1, 2, and 3 and cryptochromes 1 and 2. Circadian changes in gene expression and cardiac function are linked to the cardiomyocyte molecular clock mechanism.11, 12 Bray et al13 showed that transgenic mice that selectively overexpress a dominant-negative CLOCK mutation in cardiomyocytes alter gene expression in both atrial and ventricular myocytes, heart rate, contractile function, and metabolism. We recently found that the inducible cardiomyocyte-specific deletion of Bmal1 (iCSΔBmal1−/−) in adult mice disrupts molecular clock signaling in the heart, causes a loss in the circadian expression of the Na+ channel gene Scn5a (Nav1.5), decreases macroscopic Na+ current recorded from isolated ventricular cardiomyocytes, slows the heart rate, and increases the frequency of cardiac arrhythmias.8 Emerging evidence suggests that the cardiomyocyte molecular clock might regulate the expression of several cardiac K+ channels and ventricular repolarization as well.6, 7 However, these studies do not distinguish the relative contribution of the cardiomyocyte molecular clock from circadian clock signaling in other tissues. The purpose of this study was to determine how Bmal1 expression in cardiomyocytes contributes to changes in K+ channel expression and ventricular repolarization.
Section snippets
Inducible deletion of Bmal1 in adult cardiomyocytes
All animal procedures were conducted in compliance with the guidelines of the Association for Assessment and Accreditation of Laboratory Animal Care and were approved by the Institutional Animal Care and Use Committee of the University of Kentucky. The inducible cardiac-specific ΔBmal1 (iCSΔBmal1) mouse model used for these studies was described previously.8 Cre-recombination was activated once the mice reached 12 weeks of age by intraperitoneal injections of tamoxifen (2 mg/d) for 5
Kcnh2 is a candidate clock-controlled gene
We investigated the role of cardiomyocyte molecular clock in the regulation of cardiac K+ channel gene expression important in mouse and human ventricular repolarization (Online Supplemental Table 1). To identify K+ channel gene candidates that are expressed in a circadian pattern, we used the high-resolution CircaDB microarray data set for the heart (http://circadb), which analyzed gene expression every 2 hours for 48 hours in combination JTK_CYCLE statistical analysis.21 We then confirmed
Discussion
The circadian molecular clock is a highly conserved, cell-autonomous, transcriptionally mediated mechanism that provides an evolutionary advantage by optimizing an organism’s physiology to anticipate the daily variation in the environment.24 To date, there is only tangential and circumstantial evidence linking the cardiomyocyte molecular clock to circadian changes in K+ channel expression and cardiac electrophysiology. In 2003, Yamashita et al6 hypothesized that the expression of certain
Conclusion
This is the first work to clearly demonstrate that intrinsic circadian mediators, including the cardiomyocyte molecular clock, are modulators of the electrical properties in the heart, which possibly contributes to the daily variation in SCD.
References (25)
- et al.
Circadian variation in the incidence of sudden cardiac death in the Framingham Heart Study population
Am J Cardiol
(1987) - et al.
Cellular oscillators: rhythmic gene expression and metabolism
Curr Opin Cell Biol
(2005) - et al.
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel
Cell
(1995) - et al.
Circadian variation in the frequency of sudden cardiac death
Circulation
(1987) The daily rhythms of genes, cells and organs: biological clocks and circadian timing in cells
EMBO Rep
(2005)- et al.
Molecular time: an often overlooked dimension to cardiovascular disease
Circ Res
(2009) - et al.
Circadian variation of cardiac K+ channel gene expression
Circulation
(2003) - et al.
Circadian rhythms govern cardiac repolarization and arrhythmogenesis
Nature
(2012) - et al.
The cardiomyocyte molecular clock, regulation of Scn5a, and arrhythmia susceptibility
Am J Physiol Cell Physiol
(2013) - et al.
Central and peripheral circadian clocks in mammals
Ann Rev Neurosci
(2012)
Clock genes in the heart: characterization and attenuation with hypertrophy
Circ Res
The intrinsic circadian clock within the cardiomyocyte
Am J Physiol Heart Circ Physiol
Cited by (0)
This work was supported by the National Institutes of Health (grant nos RC1ES018636 and AR55246 [to Dr Esser] and R01 HL087039 [to Dr Delisle]).
Dr Delisle has a research contract with Gilead Scientific.